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Asthma is a chronic allergic inflammatory disease with airway remodeling including fibrotic changes. Morimoto and colleagues find that the IL-33-ST2-amphiregulin-EGRF-osteopontin axis directs fibrotic responses in chronic allergic inflammation with the involvement of airway epithelial cells, pathogenic memory Th2 cells, and inflammatory eosinophils in both mouse and human.
SUMMARY
Memory T cells provide long-lasting protective immunity, and distinct subpopulations of memory T cells drive chronic inflammatory diseases such as asthma. Asthma is a chronic allergic inflammatory disease with airway remodeling including fibrotic changes. The immunological mechanisms that induce airway fibrotic changes remain unknown. We found that interleukin-33 (IL-33) enhanced amphiregulin production by the IL-33 receptor, ST2 hi memory T helper 2 (Th2) cells. Amphiregulin-epidermal growth factor receptor (EGFR)-mediated signaling directly reprogramed eosinophils to an inflammatory state with enhanced production of osteopontin, a key profibrotic immunomodulatory protein. IL-5-producing memory Th2 cells and amphiregulin-producing memory Th2 cells appeared to cooperate to establish lung fibrosis. The analysis of polyps from patients with eosinophilic chronic rhinosinusitis revealed fibrosis with accumulation of amphiregulin-producing CRTH2 + Th2 cells and osteopontin-producing eosinophils. Thus, the IL-33-amphiregulin-osteopontin axis directs fibrotic responses in eosinophilic airway inflammation and is a potential target for the treatment of fibrosis induced by chronic allergic disorders.
INTRODUCTION
Asthma is characterized by chronic airway inflammation, mucus hyperproduction, airway hyper-responsiveness (AHR), and variable airway obstruction (Busse and Lemanske, 2001; Kim et al., 2010) . Airway remodeling, structural alterations of the airway wall such as subepithelial thickening, vascular changes, and fibrosis are central to the irreversible pathology of asthma (Al-Muhsen et al., 2011; Foster et al., 2017; Lambrecht and Hammad, 2012) . Airway remodeling causes AHR, persistent airflow limitation, and a decrease in lung function. Corticosteroids are a key medicine used for the treatment of asthma. Clinical studies regarding the therapeutic effects of corticosteroids on airway remodeling have led to controversial results (Adcock et al., 2008; Durrani et al., 2011; Hansbro et al., 2017) . About 5%-10% of asthmatics are refractory to corticosteroid treatment and often need to be hospitalized, and the degree of airway remodeling in asthmatics correlates with disease severity (Lambrecht and Hammad, 2015; Martinez and Vercelli, 2013) .
Fibrosis consists of excessive deposition of collagenous and noncollagenous extracellular matrix (ECM) components in lung parenchyma as a consequence of proliferation and activation of fibroblasts, myofibroblasts, and immune cells (Wick et al., 2013) . Fibrosis develops as a result of long-lasting inflammation such as occurs in asthma. Both innate and adaptive immunity are involved in the pathogenesis of fibrotic responses during allergic inflammation (Wick et al., 2013) . T helper 2 (Th2) cells are a central population in the pathogenesis of allergic airway inflammation and fibrosis (Gieseck et al., 2018; Nakayama et al., 2017; Wick et al., 2013) . Interleukin-5 (IL-5) is a key cytokine for the development, recruitment to inflammatory sites, and activation of eosinophils (Rosenberg et al., 2013) . Local inflammation causes recruitment of eosinophils with inflammatory features (Mesnil et al., 2016) . Eosinophil-induced inflammatory mediators such as reactive oxygen species (ROS), cytokines, and lipid mediators damage airway epithelial cells and nerves and induce asthmatic inflammation together with AHR (Rosenberg et al., 2013; Rothenberg and Hogan, 2006) . Eosinophils are also involved in the pathogenesis of airway remodeling characterized by collagen fibril deposition (Humbles et al., 2004) , but the molecular mechanisms through which eosinophils induce the fibrotic changes remain uncertain. Recently, pathogenic memory Th2 cells producing high amounts of IL-5 have been shown to direct eosinophilic inflammation . They show high expression of the ST2 receptor, are selectively induced by IL-33 (the ligand of the ST2 receptor), and play critical role in the pathogenesis of chronic eosinophilic inflammation both in human and mouse systems (Endo et al., 2011 (Endo et al., , 2015 Nakayama et al., 2017) . Similar pathogenic Th2 cells producing high amounts of IL-5 have been reported in the skin of patients with atopic dermatitis (Islam et al., 2011) and in the peripheral blood of patients with eosinophilic gastrointestinal disease and asthma (Mitson-Salazar et al., 2016; Seumois et al., 2016; Wambre et al., 2017) . However, the pathogenic Th2 cell subpopulation shaping the pathology of fibrosis remains unclear.
Chronic rhinosinusitis (CRS) is a multifactorial disease associated with chronic inflammation and characteristic cytokine and airway remodeling patterns (Ball et al., 2016) . Based on diagnostic histological changes, CRS with polyps is classified as either eosinophilic CRS (ECRS) or non-eosinophilic CRS (NECRS) (Hamilos, 2015) . Patients with ECRS often present with asthma and their polyps exhibit eosinophilic infiltration, suggesting that aberrant type 2 immune responses are involved in the pathogenesis of ECRS (Hamilos, 2015) . The pathogenesis of asthma and ECRS appear to be closely related (Kobayashi et al., 2015) . Histological analysis of ECRS shows basement membrane thickening that is the result of a severe fibrotic response typified by accumulation of fibronectin and type I, III, and V collagens (Ball et al., 2016; Pawankar and Nonaka, 2007) . A high proportion of patients with ECRS are refractory to current conventional pharmacologic therapy such as corticosteroid treatment and suffer frequent disease recurrence. The precise cellular and molecular mechanisms that cause the type of persistent sino-nasal type 2 inflammation that leads to fibrosis remain unclear.
Herein, we investigated the cellular and molecular mechanisms that control the pathogenesis of airway fibrosis during chronic allergic inflammation. We found that an epithelial cytokine IL-33 drives lung fibrotic responses during antigen-induced Th2 cell-dependent allergic airway inflammation. IL-33 induced amphiregulin production by ST2 hi memory-type pathogenic Doherty et al., 2011) . In addition, the expression of molecules relevant to fibrotic responses such as Spp1 (which encodes osteopontin), Tenascin C (Tnc), Collagen type 1 alpha 1 (Col1a1), and Actin alpha 2 smooth muscle aorta (Acta2) was significantly enhanced in the lungs of mice with HDM exposure ( Figure 1B ). Genetic deletion of Il33 or Il1rl1, which encodes ST2 (a component of the IL-33 receptor), resulted in significantly reduced expression of fibrosis-related genes in the lungs together with decreased collagen deposition ( Figures 1C-1F , S1C, and S1D). Mice that had received Figure S1A ), fixed and stained with Sirius red (left) from three experiments. Scale bars, 100 mm. Shown are ratios of areas of randomly selected regions stained with Sirius red surrounding bronchi versus the areas of associated basement membranes (right). More than three mice per group were analyzed. (B, D, and F) Quantitative RT-PCR analysis of the indicated genes in the lungs of wild-type mice with or without HDM exposure (n = 3 mice per group) (B), the lungs of Il33 +/+ and Il33 À/À mice with HDM exposure (n = 3 mice per group) (D), and the lungs of Il1rl1 +/+ and Il1rl1 À/À mice with HDM exposure (n = 3 mice per group) (F).
Three independent experiments were performed with similar results. (n = 3 mice per group). Data are the mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; n.s., not significant; by unpaired t test or one-way analysis of variance (ANOVA). Please see also Figure S1 . OVA-specific memory Th2 cells followed by multiple antigen challenges also exhibited a significant increase in fibrotic changes together with increased expression of Il33 and Il25 but not Tslp in the lungs ( Figures S1E-S1H ). Il33 À/À mice that had received OVA-specific memory Th2 cells exhibited significantly decreased collagen deposition in the lungs ( Figure 1G ). The fibrosis-related genes Spp1, Tnc, Col1a1, and Acta2 were less induced by OVA inhalation in the lungs of Il33 À/À mice as compared to those of Il33 +/+ mice ( Figure 1H ). S2H ). In contrast, the majority of amphiregulin-producing cells also produced IL-4 and IL-13 ( Figure S2H ). To characterize the amphiregulin-producing memory Th2 cells and the IL-5-producing memory Th2 cells, we performed flow cytometric analyses with various antibodies. The expression of CD147, a member of the immunoglobulin superfamily, was significantly lower on amphiregulin-producing memory Th2 cells as compared to IL-5-producing memory Th2 cells ( Figure S2I ). Amphiregulinproducing memory CD4 Figure S1L ) showed significant reduction of amphiregulin-producing memory CD4 + T cells ( Figure S2N ). ILCs from inflamed lungs also Data are the mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; n.s., not significant; by unpaired t test or one-way analysis of variance (ANOVA). Please see also Figure S2 . 
Amphiregulin Stimulates Eosinophils to Produce Osteopontin via EGF Receptor Signaling
We next explored the major cellular source of osteopontin in our experimental settings. Histological analysis of inflamed lungs in mice that received OVA-specific memory Th2 cells followed by antigen challenge ( Figure S1E ) revealed that collagen was deposited adjacent to infiltrating eosinophils ( Figure S3J ). The majority of osteopontin-stained cells in the asthmatic lung were co-localized with Siglec-F + cells ( Figure 3H Figures S3K and S3L ). Amphiregulin belongs to the epidermal growth factor (EGF)-like protein family, which interacts with EGFR to transmit signals into target cells (Shoyab et al., 1989) . Compared to airway epithelial cells, bone marrow-derived eosinophils exhibited moderate expression of Egfr ( Figures S3M and S3N ). Deletion of Areg resulted in reduced Spp1 expression from eosinophils of inflamed lungs in vivo (Figure 3I) . Thus, amphiregulin-stimulated eosinophils are the main cellular source of osteopontin in lungs undergoing allergic inflammatory fibrotic responses.
Amphiregulin Induced Transcriptional Reprogramming of Eosinophils via EGF Receptor Signaling
To determine the consequence of amphiregulin stimulation in eosinophils, we examined the global gene expression profile of eosinophils after stimulation with amphiregulin for 3 days. Amphiregulin stimulation had no obvious effect on expressions of CCR3 and Siglec-F nor on the survival of eosinophils ( Figures  S4A and S4B ). Principle component analysis revealed that amphiregulin dramatically altered the eosinophil transcriptome ( Figure S4C ). Substantial numbers of genes were upregulated in eosinophils after amphiregulin stimulation ( Figure S4D ). Gene Ontology enrichment analysis of 10,899 genes indicated that amphiregulin stimulation upregulated genes related to cell activation, cell cycle processes, RNA metabolic processes, Figure S3A ). Data are the mean ± SD. **p < 0.01, ***p < 0.001, ****p < 0.0001; by unpaired t test or one-way analysis of variance (ANOVA). Please see also Figure S3 . and regulation of nuclear transport ( Figure 4A , Table S1 ). As compared to control un-stimulated eosinophils, amphiregulinstimulated eosinophils significantly upregulated genes characteristic of inflammatory eosinophils ( Figure S4E ; Mesnil et al., 2016) . Characteristic of inflammatory eosinophils, amphiregulin-stimulated eosinophils upregulated CD101 and downregulated CD62L ( Figure 4B ; Mesnil et al., 2016) . These results indicate that amphiregulin reprogrammed eosinophil gene expression toward an inflammatory state. Compared to control stimulation, amphiregulin stimulation led to 846 genes with >2-fold upregulation and 467 genes with <50% downregulation ( Figure 4C ). As expected, Spp1 was one of the genes significantly induced by amphiregulin stimulation. Among reported fibrosis-related genes (Wick et al., 2013) , Spp1 was confirmed to be upregulated by amphiregulin in eosinophils ( Figure 4D ). Quantitative RT-PCR confirmed that amphiregulin stimulation induced the expression of Spp1 in eosinophils but not in other types of cells including fibroblasts ( Figure 4E ). These results indicate that inflammatory eosinophils activated by amphiregulin expressed Spp1.
Osteopontin Secretion from Eosinophils Is Required for Fibrosis
Mice that genetically lack eosinophils (Ddbl-GATA mice) showed ameliorated fibrotic responses by both HDM exposure and OVA-alum immunization followed by OVA inhalation ( Figures  S5A-S5D ). Comparative global gene expression revealed enrichment of lung-tissue repair-related pathways in lungs from wildtype as compared to Ddbl-GATA mice ( Figures 5A and S5E) . Spp1 was one of the genes upregulated in both amphiregulinstimulated eosinophils and inflamed lungs from wild-type mice ( Figures 5B and S5F) . Using a trans-well co-culture system, Spp1 +/+ but not Spp1 À/À eosinophils induced enhanced expression of fibrosis-related molecules from fibroblasts . Consistent with these results, in vivo OVA-alum immunization followed by OVA inhalation or repetitive exposure of HDM resulted in ameliorated fibrotic changes in the lungs from Spp1 À/À mice ( Figures 5D and S5J-S5O ).
Next, to determine whether osteopontin produced by eosinophils was physiologically relevant to the induction of lung fibrotic responses in vivo, we transferred eosinophils from Spp1 +/+ mice or Spp1 À/À mice together with OVA-specific memory Th2 cells to Ddbl-GATA mice and then performed antigen challenge ( Figure S5P ). Lung collagen deposition was significantly decreased in recipients of Spp1 À/À as compared to Spp1 +/+ eosinophils ( Figure 5E ). Recipients of Spp1 À/À as compared to Spp1 +/+ eosinophils also exhibited decreased expression of fibrosis-related genes ( Figures 5F and 5G ).
Thus, osteopontin produced by eosinophils was relevant to the induction of lung fibrotic responses.
Inhibition of EGFR Signaling Ameliorates Fibrotic
Responses In Vivo Erlotinib, a receptor tyrosine kinase inhibitor acting on the EGFR (Moyer et al., 1997) , inhibited amphiregulin-induced Spp1 upregulation in eosinophils without any obvious effects in the survival of eosinophils ( Figures 6A, S6A , and S6B). Erlotinib also had no obvious effect on the survival and cytokine production of ST2 hi memory Th2 cells ( Figures S6C and S6D) . However, Erlotinib treatment in vivo resulted in significant decreases in both collagen deposition and expression of fibrosis-related genes in inflamed lungs ( Figures 6B and S6E-S6G ). Osteopontin-positive eosinophils disappeared from the inflamed lungs of mice treated with Erlotinib ( Figures 6C and 6D ). Moreover, Erlotinib treatment after the induction of fibrotic changes by repetitive exposure to HDM resulted in ameliorated fibrosis accompanied by disappearance of osteopontin-positive eosinophils ( Figures 6E-6G , S6H, and S6I). Thus, the amphiregulin-EGFR-osteopontin axis in eosinophils leads to fibrotic responses in vivo.
ECRS Polyps with Fibrotic Changes Exhibit Selective Amphiregulin Production by Memory CD4 + T Cells and Osteopontin Expression by Eosinophils
We sought to determine whether the observed mechanisms were relevant to inflammatory lesions of human chronic allergic diseases. Eosinophilic chronic rhinosinusitis (ECRS) is a chronic upper airway inflammatory disease that often presents with nasal polyps infiltrated with eosinophils . Fibronectin deposition was significantly elevated in the polyps of patient with ECRS as compared to the normal nasal mucosa ( Figure 7A ). The expression of fibrosis-related genes such as SPP1, TNC, COL1A1, ACTA2, and FN1 was significantly increased in ECRS polyps as compared to normal nasal mucosa tissue ( Figure 7B ). The expression of AREG, IL33, IL1RL1, and Th2 cytokines was also significantly higher in the ECRS polyps ( Figures 7C and S7A ). These results prompted us to characterize amphiregulin-producing cell population(s) in local inflammatory sites. Flow cytometry analysis of infiltrating mononuclear cells from ECRS polyps revealed amphiregulin production coming mainly from CD45RO + memory-type CD4 + T cells, with a minor contribution from innate lymphoid cells (ILCs) (Figures S7B-S7D Data are the mean ± SD. **p < 0.01, ***p < 0.001, ****p < 0.0001; n.s., not significant; by unpaired t test or one-way analysis of variance (ANOVA). Please see also Figure S4 . S7F-S7H). However, distinct CD161 hi CRTH2 hi subpopulations were responsible for amphiregulin and IL-5 production ( Figures  7E, S7F , and S7G). Histological analyses of ECRS nasal polyps revealed eosinophil infiltrates associated with dense osteopontin deposits ( Figure 7F, lower panel) . Eosinophils infiltrating ECRS polyps exhibited significantly elevated expression of SPP1 as compared to circulating eosinophils in PBMCs obtained from the same patients ( Figure 7G ). The expression of SPP1 was induced by amphiregulin in circulating eosinophils, and Erlotinib constrained the induction of SPP1 (Figures 7H, S7I, and S7J) . These results show that amphiregulin-producing memory-type CD4 + T cells co-localize with ostepontin-expressing eosinophils in ECRS polyps where severe fibrotic responses were observed. Thus, we have identified an amphiregulin-producing memorytype CD4 + T cell subpopulation that may direct tissue fibrotic responses via eosinophilic osteopontin in the nasal polyps of ECRS patients.
DISCUSSION
Herein, we have identified that amphiregulin produced by memory-type Th2 cells is a key molecule in the pathogenesis of fibrosis during eosinophilic inflammation. We found that amphiregulin reprogrammed eosinophils to adopt an inflammatory phenotype with enhanced osteopontin production. The genetic deletion of ll33, Il1rl1, Areg, or Spp1 or the blockade of EGFR signaling in vivo attenuated fibrotic responses during eosinophilic inflammation in the lung. The analysis of ECRS polyps revealed severe fibrotic lesion infiltrated with osteopontin-expressing eosinophils and amphiregulin-producing CD161 + CRTH2 + memory CD4 + T cells. Amphiregulin-producing memory Th2 cells were distinct from IL-5-producing memory Th2 cells, and the co-operation of both pathogenic Th2 cell subpopulations appear to be critical for the induction of fibrosis in the airways of both mice and humans. Moreover, the blockade of EGFR signaling by Erlotinib resulted in decreased amphiregulin-induced upregulation of SPP1 expression in eosinophils, indicating that the IL-33-amphiregulin-osteopontin axis could be a therapeutic target for treatment of fibrosis in chronic allergic inflammation.
IL-33 is associated with several fibrotic diseases such as hepatic fibrosis and bleomycin-induced pulmonary fibrosis via activation of type 2 innate lymphoid cells (ILC2s) and macrophages (Li et al., 2014; McHedlidze et al., 2013) . The IL-33-ST2 axis plays a protective role in cardiac fibrosis (Sanada et al., 2007) . By contrast, we demonstrated that IL-33 drove fibrotic responses in the inflamed lung through the activation of ST2 hi memorytype Th2 cells. Thus, IL-33 is a multifunctional cytokine and appears to exert distinct effects in different biological contexts. IL-33 stimulation resulted in selective production of amphiregulin by ST2 hi memory-type Th2 cells in models of allergen-induced allergic airway inflammation. Amphiregulin, encoded by Areg, belongs to the epidermal growth factor (EGF) family and signals through the EGFR system (Shoyab et al., 1989) . Amphiregulin is known to promote tissue-protective epithelial responses in the intestine during helminth infection (Zaiss et al., 2006) . Amphiregulin produced by regulatory T (Treg) cells, mast cells, and ILC2s has also been found to be involved in the process of tissue repair of muscle and lungs, thereby contributing to tissue homeostasis (Arpaia et al., 2015; Burzyn et al., 2013; Monticelli et al., 2011; Okumura et al., 2005; Zaiss et al., 2013) . Although uncontrolled tissue repair due to chronic inflammation may cause fibrosis (Wick et al., 2013) , until the current work the pathogenic role of amphiregulin in the induction of fibrosis had not been not established. In the present study, we have shown that genetic ablation of amphiregulin resulted in ameliorated fibrotic responses, which indicates that amphiregulin contributes to the pathogenesis of inflammation-associated fibrosis. Moreover, we found that ST2 hi memory-type Th2 cells were the major producer of amphiregulin in antigen-induced eosinophilic airway inflammation models and thus are key players in lung fibrotic responses. We also found that the majority of amphiregulin-producing ST2 hi memory-type Th2 cells did not produce IL-5. These results indicate functional heterogeneity of ST2 hi memory Th2 cell populations: IL-5-producing cells to recruit and activate eosinophils and amphiregulin-producing cells to induce fibrotic responses. A two-step interaction between eosinophils and distinct ST2 hi memory Th2 cell subpopulations producing either IL-5 or amphiregulin may underlie the establishment of pathological eosinophil-induced fibrotic changes. Data are the mean ± SD. **p < 0.01, ***p < 0.001; by unpaired t test or one-way analysis of variance (ANOVA). Please see also Figure S5 . In the current study, we also identified eosinophils as critical target cells for amphiregulin in the process of inflammationassociated fibrosis. Amphiregulin is well known to stimulate lung epithelial cells to undergo proliferation and enhanced mucin production (Okumura et al., 2005; Zaiss et al., 2006) . Amphiregulin also promotes the proliferation of lung fibroblasts (AlMuhsen et al., 2011) . Amphiregulin from tissue-resident Treg cells contributes to the downregulation of collagens from injured muscle cells (Burzyn et al., 2013) . Other groups have reported that amphiregulin from cardiac Ly6C lo macrophages is involved in the adaptive response to pressure overload in the heart (Fujiu et al., 2017) . Our genome-wide analyses revealed that amphiregulin stimulation induced transcriptional reprogramming in eosinophils, marked by upregulation of inflammatory genes. One of the genes upregulated by amphiregulin stimulation in eosinophils was Spp1, a major component of noncollagenous ECM in fibrotic tissues and a contributor to the pathogenesis of fibrosis (Denhardt et al., 2001; Sabo-Attwood et al., 2011) . Refractory asthma is often associated with tissue fibrosis leading to a decrease in lung function. Our findings indicate that eosinophils directly produce noncollagenous ECM and contribute to tissue fibrosis in allergic airway inflammation. The analysis of ECRS polyps revealed significantly increased deposition of fibronectin and upregulation of various fibrosis-related genes. Previous work has shown that osteopontin is upregulated in nasal polys from patients with chronic rhinosinusitis with nasal polyps (CRSwNP) (Liu et al., 2015) . Other work has shown that osteopontin is expressed in eosinophils from patients with atopic dermatitis and that expression of osteopontin is enhanced by GM-CSF and IL-5 (Puxeddu et al., 2010) . In this study, we detected the accumulation of both amphiregulin-producing CD161 hi CRTH2 hi memory-type CD4 + T cells and osteopontin-producing eosinophils in ECRS polyps. But very limited numbers of ILC2s were detected in the nasal polyps of patients with ECRS. In particular, amphiregulin production was less than 1.0% in ILC2s as compared to T cells. Though perhaps unexpected given observations from previous publications (Bal et al., 2016; Ho et al., 2015) , we provided a direct comparison of amphiregulin production among T cells and ILC2s. Our results show that in ECRS polyps, the major source of amphiregulin is a CD161 hi CRTH2 hi memory-type CD4 + T cell. Cells with this phenotype have been shown to produce large amounts of IL-5 and have been appreciated as ''pathogenic'' in various human allergic diseases, particularly in association with eosinophilic inflammation such as in eosinophilic esophagitis (Mitson-Salazar et al., 2016; Nakayama et al., 2017; Wambre et al., 2017) . In the current study, similar to results from mouse systems, we detected both IL-5-producing and amphiregulinproducing subsets among CD161 hi CRTH2 hi memory-type CD4 + T cells infiltrating ECRS polyps. The majority of amphiregulin producers showed limited production of IL-5. Thus, the current study demonstrates functional heterogeneity of pathogenic memory Th2 cells in both mouse and human systems. Treatment with CRTH2 antagonist OC000459 causes reduction of extracellular deposits in patients with eosinophilic esophagitis (Straumann et al., 2013) . Thus, the amphiregulinosteopontin pathway could be a potential therapeutic target for patients with eosinophilic inflammatory disorders including ECRS that are refractory to corticosteroid treatment.
In summary, we have identified the cellular and molecular mechanisms that control the induction of airway fibrotic responses during chronic allergic inflammation. We have elucidated the critical role of the IL-33-amphiregulin-osteopontin axis in the interaction between ST2 hi memory-type pathogenic Th2 cells and eosinophils and how this shapes the pathology of fibrotic responses in allergic inflammation, and provides the molecular basis for the development of potential therapeutic strategies for intractable inflammation-associated fibrotic diseases.
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(EP5, Santa Cruz Biotechnology) was used for immunohistochemistry staining for human samples. The area of peribronchial Sirius Red staining in a paraffin-embedded lung was outlined and quantified using a light microscope (BIOREVO; KEYENCE Corp., Osaka, Japan) attached to an image-analysis system (Photoshop; Adobe Systems Inc., San Jose, California, USA). Results are expressed as the area of Sirius Red staining per micrometer length of basement membrane of bronchioles with 100 mm internal diameter. At least five bronchioles were counted in each slide. Basement membrane thickening was assessed as basement membrane per micrometer length of bronchus epithelium as previously reported (Valladao et al., 2016) . At least five bronchioles were counted in each slide. Histological scores were determined based on the presence of the following: perivascular eosinophils (0-2), alveolar eosinophils (0-2), perivascular mononuclear cells (0-2), alveolar mononuclear cells (0-2), epithelial desquamation (normal = 0; elongation/distortion = 1; elongation, infolding, and narrowing = 2; loss of cells with broken airways = 3).
The Generation and Culture of Effector and Memory Th2 Cells Splenic CD62L + CD44 -KJ1 + CD4 + T cells from DO11.10 OVA-specific TCR Tg mice were stimulated with an OVA peptide (Loh15, 1 mM) plus antigen-presenting cells (irradiated splenocytes) under Th2-cell-culture conditions (25 U/ml IL-2, 10 U/ml IL-4, and anti-IFN-g monoclonal antibody) for 6 days in vitro. The effector Th2 cells (3 3 10 7 ) were transferred intravenously into BALB/c nu/nu or BALB/c recipient mice. Five weeks after cell transfer, KJ1 + CD4 + T cells in the spleen were purified by autoMACS Sorter (Miltenyi Biotec, Bergisch Gladbach, Germany) and cell sorting (BD Aria II) and used as memory Th2 cells. Unless otherwise specifically noted, cells were stimulated with IL-33 at a concentration of 10 ng/ml for 72 hours. In some experiments, cells were stimulated with IL-25 (10 ng/ml) or TSLP (10 ng/ml).
Flow cytometry and sorting
Mouse memory Th2 cells were stained with anti-IL1rL1(ST2) (DIH9, BioLegend), and two subpopulations (ST2 low , ST2 high ) were purified by FACS. Memory Th2 cells were stimulated with immobilized anti-TCRb for 4 hours. Anti-Amphiregulin (206220, R&D Systems) was conjugated by ourselves using an Antibody Labeling Kit (Thermo Fisher Scientific) and used for intracellular staining of mouse samples. Anti-IL-5 (TRFK5, BioLegend), Anti-IL-4 (11B11, BioLegend) and Anti-IL-13 (eBio13A, eBioscience) were used for intracellular staining of mouse samples.
Anti-Siglec-F (E50-2440, BD Biosciences), Anti-CCR3 (83101, R&D Systems), Anti-CD101 (Moushi101, eBioscience) and Anti-CD62L (MEL-14, BioLegend) were used for cell surface staining of mouse samples.
T cells from PBMC and dissociated cells from the ECRS polyps were stained with anti-CD4 (OKT4, BioLegend), anti-CD45RO (UCHL1, BioLegend), anti-CD161 (HP-3G10, BioLegend), anti-CRTH2 (BM16, BioLegend), anti-Lineage Cocktails (BioLegend) and anti-CD127 (A019D5, BioLegend). Anti-Amphiregulin (31221, R&D Systems) was conjugated by ourselves using an Antibody Labeling Kit (Thermo Fisher Scientific) and used for intracellular staining for human samples. Anti-IL-5 (TRFK5, BioLegend) and anti-IFNg (4S.B3, BioLegend) were used for intracellular staining of human samples.
Cell Viability Assay
Experiments were performed by using a FITC Annexin V Apoptosis Detection Kit I (BD Biosciences). Cells were washed, re-suspended in 100 mL 1X Binding Buffer, treated with 5 mL of FITC Annexin V and 5 mL PI, incubated for 15 min at RT in the dark, supplemented with 400 mL of 1X Binding Buffer and finally analyzed by flow cytometry.
ST2 Neutralizing Assay
Cells were incubated in the presence or absence of either anti-ST2 antibody (R&D Systems) or an isotype control antibody at a concentration of 1 mg/ml for 24 hours. After washing, cells were stimulated with IL-33 at a concentration of 10 ng/ml for 3 days.
Erlotinib Treatment
Erlotinib (Selleck, Houston, TX, USA) was dissolved in DMSO as described in the product manual. For in vitro experiments, Erlotinib was used to treat cells at a concentration of 100 nM and an equal amount of DMSO was used as a control. For in vivo experiments, Erlotinib was diluted with PBS and administered intraperitoneally at 12.5 mg/kg/day and an equal amount of DMSO diluted with PBS was administered intraperitoneally as a control.
Quantitative Real-Time PCR Total RNA isolation, cDNA synthesis, and Quantitative real-time PCR was described previously (Endo et al., 2015) . Primers and Roche Universal probes were purchased from Sigma and Roche, respectively. Primers and TaqMan probes were purchased from Applied Biosystems. Gene expression was normalized with the Hprt and b-actin mRNA signals and GAPDH (Human) mRNA signals.
RNA Sequencing RNA-seq was carried out as previously described (Onodera et al., 2015) . Total cellular RNA was extracted with TRIzol reagent (Invitrogen). For cDNA library construction, we used TruSeq RNA Sample Prep Kit v2 (Illumina) according to the manufacturer's protocol. Sequencing library fragments was performed on the HiSeq 1500 System. For data analysis, read sequences (50 bp) were Nasal Polyp, Peripheral Blood Mononuclear Cell and Homogenate Preparation Nasal polyp mononuclear cells (NPMCs) were obtained as previously described (Yamamoto et al., 2007) . In brief, freshly obtained nasal polyps were immediately minced and incubated in RPMI 1640 medium containing 1 mg/ml collagenase, 0.5 mg/ml hyaluronidase, and 0.2 mg/ml DNase I (Sigma-Aldrich). After incubation, NPMCs were purified by Ficoll-Hypaque technique. A volume of 1 mL of PBS was added for every 100 mg of tissue and was supplemented with aprotinin and leupeptin (Roche). Peripheral blood mononuclear cells (PBMCs) were obtained similarly. Human eosinophils were purified by autoMACS from PBMC and from nasal polyps using the Eosinophil Isolation Kit (Miltenyi Biotec, Bergisch Gladbach, Germany Analysis and graphic display of RNA-seq data 10,899 genes in which maximum FPKM value of each gene was equal to or greater than 1.0 were used for further analysis. Principal component analysis (PCA, rgl package) was perform by R (https://www.r-project.org/). A volcano plot was constructed by R (https:// www.r-project.org/). Julia (https://julialang.org/, PyPlot and seaborn package) was used for constructing heatmaps.
Gene Ontology enrichment analysis Gene Ontology enrichment analysis was performed with 10,899 genes by R and GSA package and c5.all.v5.2.symbols.gmt as GO term database (http://software.broadinstitute.org/gsea/msigdb) with FDR < 0.10 and p value < 0.01 as the cutoff value. A network of enriched GO terms was generated by Julia. Connection of the nodes was determined with cutoff level of Simpson coefficient R 0.5. The network graph was visualized using Cytoscape (http://www.cytoscape.org/) and the Force Directed Layout with Simpson coefficient as a weight for the length of the spring.
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